Literature DB >> 21892879

Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs.

Yeamin Huh1, David E Smith, Meihau Rose Feng.   

Abstract

Human clearance prediction for small- and macro-molecule drugs was evaluated and compared using various scaling methods and statistical analysis. Human clearance is generally well predicted using single or multiple species simple allometry for macro- and small-molecule drugs excreted renally. The prediction error is higher for hepatically eliminated small-molecules using single or multiple species simple allometry scaling, and it appears that the prediction error is mainly associated with drugs with low hepatic extraction ratio (Eh). The error in human clearance prediction for hepatically eliminated small-molecules was reduced using scaling methods with a correction of maximum life span (MLP) or brain weight (BRW). Human clearance of both small- and macro-molecule drugs is well predicted using the monkey liver blood flow method. Predictions using liver blood flow from other species did not work as well, especially for the small-molecule drugs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21892879      PMCID: PMC4181675          DOI: 10.3109/00498254.2011.598582

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  147 in total

1.  Preclinical pharmacokinetic evaluation of the respiratory syncytial virus-specific reshaped human monoclonal antibody RSHZ19.

Authors:  C B Davis; T W Hepburn; J J Urbanski; D C Kwok; T K Hart; D J Herzyk; S G Demuth; M Leland; G R Rhodes
Journal:  Drug Metab Dispos       Date:  1995-10       Impact factor: 3.922

2.  Interspecies scaling of clearance and volume of distribution for digoxin-specific Fab.

Authors:  N A Grene-Lerouge; M I Bazin-Redureau; M Debray; J M Scherrmann
Journal:  Toxicol Appl Pharmacol       Date:  1996-05       Impact factor: 4.219

3.  Pharmacokinetic and hemostatic properties of the recombinant plasminogen activator bm 06.022 in healthy volunteers.

Authors:  U Martin; E von Möllendorff; W Akpan; R Kientsch-Engel; B Kaufmann; G Neugebauer
Journal:  Thromb Haemost       Date:  1991-11-01       Impact factor: 5.249

4.  Predicting toxicokinetic parameters in humans from toxicokinetic data acquired from three small mammalian species.

Authors:  K Bachmann
Journal:  J Appl Toxicol       Date:  1989-10       Impact factor: 3.446

Review 5.  Panitumumab the first fully human monoclonal antibody: from the bench to the clinic.

Authors:  Michael Cohenuram; Muhammad Wasif Saif
Journal:  Anticancer Drugs       Date:  2007-01       Impact factor: 2.248

6.  Chronopharmacology of granulocyte colony-stimulating factor in mice.

Authors:  S Ohdo; N Arata; T Furukubo; E Yukawa; S Higuchi; S Nakano; N Ogawa
Journal:  J Pharmacol Exp Ther       Date:  1998-04       Impact factor: 4.030

Review 7.  Interspecies scaling of therapeutic monoclonal antibodies: initial look.

Authors:  Jie Ling; Honghui Zhou; Qun Jiao; Hugh M Davis
Journal:  J Clin Pharmacol       Date:  2009-10-16       Impact factor: 3.126

8.  Pharmacokinetic, biliary excretion, and metabolic studies of 14C-furosemide in the rat.

Authors:  J Prandota; A W Pruitt
Journal:  Xenobiotica       Date:  1991-06       Impact factor: 1.908

9.  Modeling and allometric scaling of s(+)-ketoprofen pharmacokinetics and pharmacodynamics: a retrospective analysis.

Authors:  E-I Lepist; W J Jusko
Journal:  J Vet Pharmacol Ther       Date:  2004-08       Impact factor: 1.786

10.  Renal dose response and pharmacokinetics of atrial natriuretic factor in dogs.

Authors:  P Cernacek; E Maher; J C Crawhall; M Levy
Journal:  Am J Physiol       Date:  1988-12
View more
  22 in total

Review 1.  Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape.

Authors:  Ali Kermanizadeh; Leagh G Powell; Vicki Stone; Peter Møller
Journal:  Int J Nanomedicine       Date:  2018-11-16

Review 2.  Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies.

Authors:  Miroslav Dostalek; Iain Gardner; Brian M Gurbaxani; Rachel H Rose; Manoranjenni Chetty
Journal:  Clin Pharmacokinet       Date:  2013-02       Impact factor: 6.447

3.  In Vitro-In Vivo Extrapolation and Hepatic Clearance-Dependent Underprediction.

Authors:  Christine M Bowman; Leslie Z Benet
Journal:  J Pharm Sci       Date:  2019-02-25       Impact factor: 3.534

4.  Utility of physiologically based pharmacokinetic (PBPK) modeling in oncology drug development and its accuracy: a systematic review.

Authors:  Teerachat Saeheng; Kesara Na-Bangchang; Juntra Karbwang
Journal:  Eur J Clin Pharmacol       Date:  2018-07-05       Impact factor: 2.953

5.  Influence of Molecular size on the clearance of antibody fragments.

Authors:  Zhe Li; Ben-Fillippo Krippendorff; Dhaval K Shah
Journal:  Pharm Res       Date:  2017-07-05       Impact factor: 4.200

6.  Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents.

Authors:  He Wei; Agata Wiśniowska; Jingxuan Fan; Peter Harvey; Yuanyuan Li; Victoria Wu; Eric C Hansen; Juanye Zhang; Michael G Kaul; Abigail M Frey; Gerhard Adam; Anatoly I Frenkel; Moungi G Bawendi; Alan Jasanoff
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-19       Impact factor: 11.205

7.  Across-species meta-analysis of dexamethasone pharmacokinetics utilizing allometric and scaling modeling approaches.

Authors:  Dawei Song; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2021-03-17       Impact factor: 1.627

Review 8.  Examination of Urinary Excretion of Unchanged Drug in Humans and Preclinical Animal Models: Increasing the Predictability of Poor Metabolism in Humans.

Authors:  Nadia O Bamfo; Chelsea Hosey-Cojocari; Leslie Z Benet; Connie M Remsberg
Journal:  Pharm Res       Date:  2021-07-12       Impact factor: 4.580

9.  Quantifying and Communicating Uncertainty in Preclinical Human Dose-Prediction.

Authors:  M Sundqvist; A Lundahl; M B Någård; U Bredberg; P Gennemark
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2015-04-16

10.  Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance.

Authors:  Daniel Scotcher; Christopher Jones; Amin Rostami-Hodjegan; Aleksandra Galetin
Journal:  Eur J Pharm Sci       Date:  2016-03-28       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.